Kennedy fills long-vacant preventive medicine panel with eight new appointees

Health Secretary Robert F. Kennedy Jr. has named eight new members to the US Preventive Services Task Force (USPSTF), filling a 16-seat federal panel whose guidance shapes which preventive medical services millions of Americans receive at no out-of-pocket cost.

The task force evaluates clinical evidence and issues graded recommendations — on an A through D scale — covering services ranging from depression screening and statin therapy to colonoscopies and mammograms. Under federal rules, insurers must cover any preventive service earning an A or B grade without cost-sharing, giving the panel’s decisions direct consequences for both patients and the insurance industry.

The appointments come after an extended hiatus for the panel. Kennedy had paused its operations for more than a year, canceling scheduled meetings and leaving expiring seats unfilled. In May, he removed two of the task force’s leaders, drawing criticism from physician groups and fueling concern that the traditionally nonpartisan body could be reshaped along ideological lines — a pattern critics point to in his earlier restructuring of the CDC’s vaccine advisory committee.

Supporters of the task force’s prior structure have emphasized that its recommendations rest on a documented, evidence-based framework, and that any shift in membership could ripple through insurance coverage mandates nationwide. The names and credentials of the new members are expected to draw scrutiny as stakeholders assess whether the panel maintains its scientific independence.

The story sits outside the typical semiconductor, software, and AI beat this publication covers, but the panel’s decisions carry financial weight across the healthcare and insurance sectors. (No publicly traded technology companies from our coverage universe are directly involved in this story.)

What to watch

• Publication of the new members’ names, affiliations, and relevant clinical qualifications.
• Whether the task force resumes its regular meeting schedule and public comment process.
• Any updates to existing A or B graded recommendations on screening and preventive services, which would trigger insurance coverage changes.
• Reactions from medical professional societies and insurer groups as the reconstituted panel begins its work.

Source: original release